Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin Regimen for Patients Infected with Chronic Hepatitis C Virus Genotype 1 in Malaysia
Clicks: 228
ID: 92158
2020
| Reference Key |
shafie2020costeffectivenessvalue
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Shafie, A. |
| Journal | value in health regional issues |
| Year | 2020 |
| DOI | 10.1016/j.vhri.2019.09.005 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.